Exploring Inpatient Hospitalizations and Morbidity in Patients With Adrenal Insufficiency
The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Context: Patients with adrenal insufficiency (AI) (primary AI [PAI], secondary AI due to a pituitary disorder [PIT] and congenital adrenal hyperplasia [CAH]) have reduced life expectancy; however, the underlying explanation remains unknown. Objective: To evaluate characteristics, comorbidities, and hospitalizations in AI patients. Design: Retrospective observational. Setting and Population: Using a United States-based national payer database comprising of more than 108 million members, strict inclusion criteria including diagnostic codes and steroid prescription records were used to identify 10 383 adults with AI; 1014 with PAI, 8818 with PIT, and 551 with CAH. Patients were matched 1:1 to controls, based on age (±5 y), gender, insurance, and region and followed for more than 12 months. Intervention: None. Main Outcome Measures: Demographic variables, comorbidities (diabetes mellitus [DM] types 1 and 2, depression, anxiety, hyperlipidemia, hypertension) and hospitalization incidence. Results: Compared with controls, patients with AI had higher odds of DM, hypertension, hyperlipidaemia, depression, and anxiety, ranging from an odds ratio (OR) of 1.51 for hyperlipidaemia in PAI to 3.85 for DM in CAH. Odds of having DM (OR, 3.85; 95% confidence interval, 2.52–5.90) or anxiety (OR, 2.99; 95% confidence interval, 2.02–4.42) compared with controls were highest in CAH, whereas depression was highest in PAI and PIT (OR, 2.40 and 2.55). ORs of hyperlipidaemia and hypertension (OR, 1.98 and 2.24) were highest in the PIT cohort. Inpatient admissions were more frequent in PAI (4.64:1; P < .0001) and PIT (4.00:1; P < .0001) than controls; infection was the most common cause for admission. Conclusion: Patients with AI carry a significant metabolic and psychiatric burden, with higher risk of comorbidities and hospital admissions than matched controls.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with adrenal insufficiency are at an increased risk of infection”
From ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency (2020) · cites this paper as [11]
Citations
Cites
Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
Self-citationVgontzas, A. N., Bixler, E. O., Lin, H.-M., Prolo, P., Mastorakos, G., Vela-Bueno, A., Kales, A., & Chrousos, G. P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7778 · Cited by 884
Charmandari, E., Nicolaides, N. C., & Chrousos, G. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61684-0 · Cited by 644
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
Premature Mortality in Patients with Addison’s Disease: A Population-Based Study
Bergthorsdottir, R., Leonsson-Zachrisson, M., Odén, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0076 · Cited by 490
Self-citationErichsen, M. M., Løvås, K., Skinningsrud, B., Wolff, A. B., Undlien, D. E., Svartberg, J., Fougner, K. J., Berg, T. J., Bollerslev, J., Mella, B., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1368 · Cited by 422
Hahner, S., Spinnler, C., Fassnacht, M., Burger-Stritt, S., Lang, K., Milovanovic, D., Beuschlein, F., Willenberg, H. S., Quinkler, M., & Allolio, B. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3191 · Cited by 394
Hillman, B. J., Joseph, C. A., Mabry, M. R., Sunshine, J. H., Kennedy, S. D., & Noether, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199012063232306 · Cited by 356
Cited by
Husebye, E. S., Pearce, S. H., Krone, N. P., & Kämpe, O. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00136-7 · Cited by 378
Hahner, S., Ross, R. J., Arlt, W., Bancos, I., Burger-Stritt, S., Torpy, D. J., Husebye, E. S., & Quinkler, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00252-7 · Cited by 223
An Update on Addison’s Disease
Barthel, A., Benker, G., Berens, K., Diederich, S., Manfras, B. J., Grüber, M., Kanczkowski, W., Kline, G. A., Kamvissi, V., Hahner, S., et al. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0804-2715 · Cited by 138
Kasai, T., Suga, H., Sakakibara, M., Ozone, C., Matsumoto, R., Kano, M., Mitsumoto, K., Ogawa, K., Kodani, Y., Nagasaki, H., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.009 · Cited by 124
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency
Arlt, W., Baldeweg, S. E., Pearce, S. H. S., & Simpson, H. L. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0361 · Cited by 107
Frara, S., Allora, A., Castellino, L., di Filippo, L., Loli, P., & Giustina, A. (2021) · Pituitary · doi:10.1007/s11102-021-01148-1 · Cited by 112
“In patients with adrenal insufficiency mortality rate appears to be more than doubled as compared to normal population, mainly due to cardiovascular disease and infections [121], particularly respiratory, which can be serious and expose to increased risk of hospitalization [122] and ICU admission [123] due to altered…”
BackgroundMazziotti, G., Formenti, A. M., Frara, S., Roca, E., Mortini, P., Berruti, A., & Giustina, A. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0154 · Cited by 96
El-Maouche, D., Hargreaves, C. J., Sinaii, N., Mallappa, A., Veeraraghavan, P., & Merke, D. P. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00208 · Cited by 93
“Data from a United States–based large national database showed that patients with adrenal insufficiency are at increased risk of hospitalizations and comorbities (27), and between 8% and 12% of adults and children with adrenal insufficiency are expected to require hospitalization because of adrenal crisis annually (16…”
BackgroundPrimary Adrenal Insufficiency: Managing Mineralocorticoid Replacement Therapy
Esposito, D., Pasquali, D., & Johannsson, G. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01928 · Cited by 59
Self-citationManaging common endocrine disorders amid COVID-19 pandemic
Pal, R., & Bhadada, S. K. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.05.050 · Cited by 52
“Even patients with secondary adrenal insufficiency are at a high risk of infections and hence need to take extra precautions amid COVID-19 pandemic [28].”
British Society of Gastroenterology guidelines for diagnosis and management of autoimmune hepatitis
Gleeson, D. C., Bornand, R., Brownlee, A., Dhaliwal, H., Dyson, J. K., Hails, J., Henderson, P., Kelly, D. A., Mells, G. F., Miquel, R., et al. (2025) · Gut · doi:10.1136/gutjnl-2024-333171 · Cited by 52
Skov, J., Sundström, A., Ludvigsson, J. F., Kämpe, O., & Bensing, S. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02298 · Cited by 44
Determinants of self-reported health outcomes in adrenal insufficiency: a multisite survey study
Li, D., Genere, N., Behnken, E., Xhikola, M., Abbondanza, T., Vaidya, A., & Bancos, I. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa668 · Cited by 44
Approach to the Patient With Glucocorticoid-induced Adrenal Insufficiency
Borresen, S. W., Klose, M., Glintborg, D., Watt, T., Andersen, M., & Feldt‐Rasmussen, U. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac151 · Cited by 48
Frara, S., Loli, P., Allora, A., Santini, C., di Filippo, L., Mortini, P., Fleseriu, M., & Giustina, A. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09672-y · Cited by 44
Johannsson, G., & Ragnarsson, Ó. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13382 · Cited by 46
Self-citationIatrogenic adrenal insufficiency in adults
Martin‐Grace, J., Tomkins, M., O’Reilly, M., & Sherlock, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00929-x · Cited by 40
“…insufficiency of varying aetiology, found that patients with adrenal insufficiency had poorer metabolic health (increased risk of diabetes mellitus, hypertension and dyslipidaemia), increased risk of depression and anxiety, and more frequent hospitalizations compared with matched controls 34 .”
Ngaosuwan, K., Johnston, D. G., Godsland, I. F., Cox, J., Majeed, A., Quint, J. K., Oliver, N. S., & Robinson, S. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab063 · Cited by 35
Li, D., Brand, S., Hamidi, O., Westfall, A., Suresh, M., Else, T., Vaidya, A., & Bancos, I. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac175 · Cited by 34
Factors impacting on the action of glucocorticoids in patients receiving glucocorticoid therapy
Dineen, R., Stewart, P. M., & Sherlock, M. (2019) · Clinical Endocrinology · doi:10.1111/cen.13837 · Cited by 30
Self-citationLongitudinal AddiQoL scores may identify higher risk for adrenal crises in Addison’s disease
Meyer, G., Koch, M., Herrmann, E., Bojunga, J., & Badenhoop, K. (2018) · Endocrine · doi:10.1007/s12020-017-1513-0 · Cited by 29
Modified-Release Hydrocortisone: Is It Time to Change Clinical Practice?
Stewart, P. M. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00046 · Cited by 30
“[3] was supported by Shire Pharmaceuticals.”
BackgroundSelf-citationEbrahimi, F., Kutz, A., Wagner, U., Illigens, B. M. W., Siepmann, T., Schüetz, P., Christ‐Crain, M., Müeller, B., & Christ, E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa517 · Cited by 28
Taga, S., Suga, H., Nakano, T., Kuwahara, A., Inoshita, N., Kodani, Y., Nagasaki, H., Sato, Y., Tsumura, Y., Sakakibara, M., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.05.002 · Cited by 25
“Furthermore, physiological adrenocorticotropic hormone (ACTH) requirements fluctuate with circadian rhythms and external stress (Hahner et al., 2015; Stewart et al., 2016).”
Hammarstrand, C., Ragnarsson, Ó., Bengtsson, O., Bryngelsson, I., Johannsson, G., & Olsson, D. S. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0370 · Cited by 25
Self-citationCharacterization of patients with adrenal insufficiency and frequent adrenal crises
Quinkler, M. O., Murray, R. D., Zhang, P., Marelli, C., Petermann, R., Isidori, A. M., Ekman, B., & _, _. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1324 · Cited by 26
Self-citationHealth Care Burden in Patients With Adrenal Insufficiency
Gunnarsson, C., Ryan, M. P., Marelli, C., Baker, E. R., Stewart, P. M., Johannsson, G., & Biller, B. M. K. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2016-1064 · Cited by 28
“This study used the same database and patient acquisition as our recent study on comorbidities of patients with AI [9], which used administrative health claims data from Truven Health MarketScan® Commercial and Medicare databases from January 2006 to June 2011, including a total of 108,271,287 patients.”
BackgroundMethodInfluentialSelf-citationCOVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society
Ku, C. R., Jung, K. Y., Ahn, C. H., Moon, J. S., Lee, J. H., Kim, E. H., Kwon, H., Kim, H. K., Suh, S., Hong, S., et al. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.404 · Cited by 23
“vaccines or live-attenuated vaccines such as influenza vaccines [11,40].”
BackgroundInfluentialThe management of glucocorticoid deficiency: Current and future perspectives
Dineen, R., Martin‐Grace, J., Thompson, C. J., & Sherlock, M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.03.006 · Cited by 21
Ebrahimi, F., Widmer, A., Wagner, U., Müeller, B., Schüetz, P., Christ‐Crain, M., & Kutz, A. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0469 · Cited by 21
Graf, A., Marcus, H. J., & Baldeweg, S. E. (2020) · Pituitary · doi:10.1007/s11102-020-01106-3 · Cited by 18
Serum Morning Cortisol as A Screening Test for Adrenal Insufficiency
Montes‐Villarreal, J., Pérez-Arredondo, L. A., Rodríguez‐Gutiérrez, R., González-Colmenero, A. D., Solís, R. C., González‐González, J. G., & Mancillas‐Adame, L. G. (2019) · Endocrine Practice · doi:10.4158/ep-2019-0327 · Cited by 19
Shepherd, L. M., Schmidtke, K. A., Hazlehurst, J., Melson, E., Dretzke, J., Hawks, N., Arlt, W., Tahrani, A. A., Swift, A., & Carrick‐Sen, D. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1248 · Cited by 18
“4 days for matched controls and are more likely to stay in hospital eight to ten days longer (5).”
BackgroundInfluentialHarasymiw, L. A., Grosse, S. D., & Sarafoglou, K. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa152 · Cited by 13
“We adapted our approach from Stewart and colleagues [33] and Jenkins-Jones and colleagues [34], who used national administrative data sets in the United States and United Kingdom, respectively, to identify patients with CAH.”
MethodApplication of pluripotent stem cells for treatment of human neuroendocrine disorders
Suga, H. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2880-4 · Cited by 12
Hypothalamo-Pituitary-Adrenal Axis in Depressive Disorders and Treatment Resistance
Yunilaynen, O. A., Starostina, E. G., & Oleichik, I. V. (2023) · Psikhiatriya · doi:10.30629/2618-6667-2023-21-1-73-90 · Cited by 10
Ebrahimi, F., Andereggen, L., & Christ, E. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09888-8 · Cited by 13
“Depending on the extent of hypopituitarism, individuals may be at higher risk of hospitalization, especially when secondary AI [4] or AVP-deficiency [5] are diagnosed.”
BackgroundHealthcare cost and survival in patients with non-functioning pituitary adenoma
Olsson, D. S., Svensson, M., Labori, F., Geer, A. D., & Johannsson, G. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad057 · Cited by 10
Self-citationChantzichristos, D., Persson, A., Miftaraj, M., Eliasson, B., Svensson, A.-M., & Johannsson, G. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02064 · Cited by 9
Self-citationGroot, C. J. D., Poitou, C., Coupaye, M., Clément, K., Paschou, S. Α., Charmandari, E., Kanaka‐Gantenbein, C., Wabitsch, M., Buddingh, E. P., Nieuwenhuijsen, B., et al. (2021) · Endocrine · doi:10.1007/s12020-021-02619-y · Cited by 10
Self-citationBergthorsdottir, R., Espósito, D., Olsson, D. S., Ragnarsson, Ó., Dahlqvist, P. M., Bensing, S., Nåtman, J., Johannsson, G., & Nyberg, F. (2023) · Journal of Internal Medicine · doi:10.1111/joim.13731 · Cited by 9
Self-citationKu, E. J., Song, K., Kim, K. M., Seo, G. H., & Yoo, S. J. (2023) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1607 · Cited by 8
“Additionally, patients with adrenal insufficiency are more likely to have an infection-induced adrenal crisis than those without, which is a serious complication that may lead to death [21,22].”
BackgroundChiloiro, S., Vicari, A., Mongelli, G., Costanza, F., Giampietro, A., Mattogno, P. P., Lauretti, L., Olivi, A., Marinis, L. D., Doglietto, F., et al. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09898-6 · Cited by 8
“…and observational study of 8818 patients, Stewart and co-authors demonstrated that treatment with hydrocortisone (at a dose of less than 50 mg daily) was associated with an increased risk of arterial hypertension, type 2 diabetes mellitus and dyslipidaemia compared with healthy controls [151].”
BackgroundAdrenal Insufficiency: Investigating Prevalence and Healthcare Utilization Using Administrative Data
Sekhon, S. S., Crick, K., Myroniuk, T. W., Hamming, K. S. C., Ghosh, M., Campbell-Scherer, D. L., & Yeung, R. O. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab184 · Cited by 7
“Studies in the United States have shown that patients with AI have higher rates of healthcare utilization compared to matched controls [10,11].”
BackgroundGlucocorticoid replacement therapies: past, present and future
Liew, S.-Y., Akker, S. A., Guasti, L., & Pittaway, J. F. H. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.08.011 · Cited by 8
Burger‐Stritt, S., Hahner, S., Chifu, I. O., Quinkler, M. O., Altieri, B., Hannemann, A., Völzke, H., Lang, K., Reisch, N., Pamporaki, C., et al. (2023) · Hormone and Metabolic Research · doi:10.1055/a-2190-3735 · Cited by 7
“Excepting patients with secondary AI from cohort 2, we did not find a relevant increase in the risk for cardiovascular risk factors in patients compared to controls as previously suggested by other studies [8].”
BackgroundResultInfluentialA new primate model of hypophyseal dysfunction
Kawabata, T., Suga, H., Takeuchi, K., Nagata, Y., Sakakibara, M., Ushida, K., Ozone, C., Enomoto, A., Kawamoto, I., Itagaki, I., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-90209-3 · Cited by 6
Clinical features, investigation, and management of Addison's disease
Dong, J., Hahner, S., Bancos, I., & Tomlinson, J. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00393-6 · Cited by 5
Endocrinological diagnosis and replacement therapy for hypopituitarism
Espósito, D., Johannsson, G., & Ragnarsson, Ó. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819949-7.00027-5 · Cited by 7
Self-citationBurger‐Stritt, S., & Hahner, S. (2016) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0042-118276 · Cited by 5
Abdallah, N., Mohamoud, A. A., Kearns, A., Abdallah, M., & Linzer, M. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102641 · Cited by 4
Prediction of diabetes mellitus induced by steroid overtreatment in adrenal insufficiency
Guarnotta, V., Tomasello, L., & Giordano, C. S. D. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-04904-w · Cited by 5
La chirurgie d’épargne surrénalienne : du cortex à la médulla
Ferrière, A., Kerlan, V., & Tabarin, A. (2017) · Annales d Endocrinologie · doi:10.1016/s0003-4266(17)30921-6 · Cited by 4
Szteroid-21-hidroxiláz-deficientia, a congenitalis adrenalis hyperplasia leggyakoribb oka
Doleschall, M., Török, D., Mészáros, K. V., Luczay, A., Halász, Z., Németh, K., Szücs, N., Kiss, R., Tõke, J., Sólyom, J., et al. (2018) · Orvosi Hetilap · doi:10.1556/650.2018.30986 · Cited by 5
“Az újszülöttkori sóvesztő krízistől eltekintve a mellékvesekrízis gyakorisága 4–5/100 beteg/év [30], amely a mai ellátási körülmények között is végződhet a beteg halálával [31].”
BackgroundJørgensen, N. T., Boesen, V. B., Borresen, S. W., Christoffersen, T., Jørgensen, N. R., Plomgaard, P., Christoffersen, C., Watt, T., Feldt‐Rasmussen, U., & Klose, M. (2024) · Endocrine · doi:10.1007/s12020-024-03711-9 · Cited by 4
Alekrish, Y., Alotaibi, M., & Ekhzaimy, A. A. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09905-w · Cited by 3
“As reported, the overall admission rates for AI patients increased by 62% from 2000 to 2019, with infections being the most common cause of admission [26].”
MARTINO, M., SALVIO, G., CUTINI, M., ARNALDI, G., & BALERCIA, G. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.21.03523-5 · Cited by 4
Pituitary Diseases and COVID-19 Outcomes in South Korea: A Nationwide Cohort Study
Ha, J., Kim, K. M., Lim, D., Song, K., & Seo, G. H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144799 · Cited by 2
Chifu, I. O., Richter, A.-L., Lippert, J., Detomas, M., Scheuermann, C., Herterich, S., Harbeck, B., Freytag, J., Altieri, B., & Hahner, S. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf383 · Cited by 2
Ekman, B., Quinkler, M. O., Zhang, P., Isidori, A. M., Murray, R. D., Wahlberg, J., & on behalf of the EU-AIR investigators (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02657-7 · Cited by 2
Stergianos, S., Everhov, A. H., Söderling, J. K., Skov, J., & Bensing, S. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf696 · Cited by 2
Predictors of 30‐day readmissions for adrenal insufficiency: A retrospective national database study
Kichloo, A., El‐amir, Z., Shaka, H., Wani, F., & Syed, S. J. (2021) · Clinical Endocrinology · doi:10.1111/cen.14500 · Cited by 3
Ten-year trends in adrenal insufficiency admissions
Shaka, H., Manz, S., El‐amir, Z., Wani, F., Salim, M., & Kichloo, A. (2022) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2022.2039503 · Cited by 2
“tension, hypovolemic shock, weakness, anorexia, fever, vomiting, electrolyte abnormalities, confusion, or coma.(4)”
Çelik, N. B., Ünsal, Y., Emet, D. C., Yeşil, A. M., Karakuş, B. Ş., Gonc, E. N., Özön, Z. A., Özmert, E. N., & Alikaşifoğlu, A. (2022) · Turkish Archives of Pediatrics · doi:10.5152/turkarchpediatr.2022.22096 · Cited by 2
“CH 21 5 (0-21) 4 (0-18) 7 (0-17) 35 (24-46) 16 (1-28)”
Adrenal crisis-induced cardiogenic shock (ACCS): a comprehensive review
Heidarpour, M., Shafie, D., Eshraghi, R., Mirjalili, S. R., Bahrami, A., & Movahed, M. R. (2024) · Heart Failure Reviews · doi:10.1007/s10741-024-10458-y · Cited by 2
“In addition, since Addison’s disease can be a presentation of APS 1 and 2, the occurrence of hypothyroidism and diabetes mellitus should bold the possibility of AI [86–88], (94).”
Cognitive Assessment in Adults With Adrenal Cortisol Insufficiency: Challenges and Opportunities
Ben-Shlomo, A., Koh, M., Kremen, S. A., & Wertheimer, J. C. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf029 · Cited by 4
Diarrhea-An uncommon presentation of tertiary adrenal insufficiency following heart transplantation
Sikanderkhel, S., Choudhry, M. W., Valentine, V. G., Al‐Dossari, G. A., & Khalife, W. I. (2017) · Journal of Cardiac Surgery · doi:10.1111/jocs.13175 · Cited by 2
Management of glucocorticoids following adrenalectomy for ACTH ‐independent Cushing's syndrome
Seejore, K., & Murray, R. D. (2018) · Clinical Endocrinology · doi:10.1111/cen.13839 · Cited by 2
Hormone replacement therapy using human iPS cell-derived pituitary organoids
Taga, S., Suga, H., Kimura, T., & Arima, H. (2020) · Drug Delivery System · doi:10.2745/dds.35.285 · Cited by 2
Menon, L., Pawar, S., & Regalla, D. K. R. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14072308 · Cited by 1
“Patients with adrenal insufficiency also have an increased risk of all-cause hospitalization, increased length of stay, and 1-year readmissions compared with controls [26].”
Langlois, D. K., Dirikolu, L., Brudvig, J. M., Lehner, A. F., Nelms, L. L., Carey, S. A., Wennogle, S. A. J., Cridge, H., Bassiouny, E., Zyskowski, J., et al. (2026) · Journal of Veterinary Internal Medicine · doi:10.1093/jvimsj/aalaf003 · Cited by 1
Rare Causes of Pediatric Primary Adrenal Insufficiency: An Observational Cohort Study
Schermesser-Sicard, M., Samara‐Boustani, D., Roucher‐Boulez, F., Pinto, G., Carel, J., Quoc, A. N., Vermillac, G., Rovani, S., Thalassinos, C., Costa, S., et al. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.05.011 · Cited by 1
Turning back the clock on adrenal insufficiency
Johannsson, G. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30431-x · Cited by 1
Self-citationBykova, A. Y., Bykov, Y. V., & Bekker, R. A. (2021) · Siberian Journal of Life Sciences and Agriculture · doi:10.12731/2658-6649-2021-13-4-316-351 · Cited by 1
Abdallah, N., Mohamoud, A. A., Daher, H., Abdallah, M., & Mehfooz, A. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.103835 · Cited by 1
The Cost of Adrenal Insufficiency in England—Analysis of NHS HES Data
Murray, R. D., Ruiz‐Casas, L., Beckett, M., Polifka, J., Cure, S., Ritz, B. R., & Wass, J. A. H. (2025) · Clinical Endocrinology · doi:10.1111/cen.15207 · Cited by 1
Unmasking adrenal insufficiency: the overlooked role of gastrointestinal symptoms
Savino, A., Bina, N., Muccichini, E., Segatta, F., Giammarco, V. D., Scardino, G., Paolo, D. D., Liparulo, L., & Radaelli, F. (2025) · The American Journal of Medicine · doi:10.1016/j.amjmed.2025.10.036 · Cited by 1
Response to the letter of Patra and colleagues
Dineen, R., & Sherlock, M. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0670 · Cited by 1
Matfin, G. (2018) · Wiley eBooks · doi:10.1002/9781119374800.ch20
Generation of Hypothalamus and Adenohypophysis from Human Pluripotent Stem Cells
Hagiwara, D., Suga, H., & Arima, H. (2021) · Masterclass in neuroendocrinology · doi:10.1007/978-3-030-86630-3_3
The effect of COVID-19 on patients with preexisting autoimmune diseases
Lastra, O. L. V., Navarro, A. O., Medina, G., Cruz-Domínguez, M. P., & Jara, L. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18566-3.00001-3
Editorial: Adrenal insufficiency: Diagnostic approaches, treatments and outcomes
Pazderska, A., Malchoff, C. D., Ragnarsson, Ó., & Valassi, E. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1180264
“Patients with AI are at increased risk of infections, and hospitalizations due to infections (3, 4).”
BackgroundOutcomes of ST-Segment Elevation Myocardial Infarction in Patients With Adrenal Insufficiency
Abdallah, N., Mohamoud, A. A., Ismayl, M., Aronow, H. D., Abdallah, M., & Goldsweig, A. M. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae186
Yoğun Bakımda Güncel Konular (Bahar)
Taşkıran, İ., Emgin, Ö., Özgüngör, Y., Haftacı, E., Güneş, M., Yavuz, M., Aydoğan, U., Aydoğan, E., Kırmızıgül, E., Çapar, A., et al. (2025) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3612
Female fertility and pregnancy in autoimmune Addison’s disease – a mini review
O’Murchadha, L., & Pazderska, A. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1510815
Adrenal Insufficiency: Diagnostic Approaches, Treatments, and Outcomes Volume II
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-7003-6
Bachmann, L. (2023) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-32138
Shrestha, E., Albert, S. G., Ghimire, A., Canales, S. P., Iqbal, I., & Akande, R. O. (2026) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2026.03.001
Yu, K., & Bancos, I. (2026) · Pituitary · doi:10.1007/s11102-026-01652-2
“Some demonstrate an increased risk of diabetes mellitus across PAI, SAI, and GIAI compared to matched controls [ 18 , 38 , 39], whereas others report no differences in glucose levels or insulin sensitivity across AI subtypes [ 36 , 40].”
Kim, H., Lin, V. H., Newfield, R. S., Dauber, A., Luo, M., Cicero, S., Li, M., Zhao, C., & Cheng, H. K.-H. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag112
“Additional studies have similarly documented persistent adrenal androgen excess and metabolic morbidity despite GC therapy [12, 18, 32, 33].”
Chiloiro, S., Vicari, A., Giampietro, A., Costanza, F., Calandrelli, R., Mattogno, P. P., D’Alessandris, Q. G., Gaudino, S., Marinis, L. D., Doglietto, F., et al. (2026) · Pituitary · doi:10.1007/s11102-026-01726-1
“In fact, as reported by Steward and coauthors the worsening of glucose metabolism occurs more frequently in patients on treatment with 50 mg or less of daily hydrocortisone [18 ].”
InfluentialComps, O., Carrera, M.-J., Garcia, S., Moltó, L., & Montes, A. (2026) · European Journal of Anaesthesiology Intensive Care · doi:10.1097/ea9.0000000000000128
Prevalence of sick leave before and after pituitary adenoma surgery
Krabbe, D., Jakobsson, S., Johannsson, G., Ragnarsson, Ó., Skoglund, T. S., Hallén, T., Palstam, A., & Sunnerhagen, K. S. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag151
Self-citationSilvestro, O., Costa, L., Ferraù, F., Merlo, E. M., Cannavò, S., Feldt-Rasmussen, U., & Martino, G. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1901783
Investigating the Lived Experience of Loved Ones Living With Persons With Adrenal Insufficiency
Low, J., Kendell, C., Peters, E., De, B., Gee, S., Ransom, T. P. P., Siddiqi, F. S., Vaninetti, N. M., Yip, C.-E., Imran, S. A., et al. (2026) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514261505274
Metadata
- Authors
- Stewart, P. M., Biller, B. M. K., Marelli, C., Gunnarsson, C., Ryan, M. P., & Johannsson, G.
- Affiliations
- Medical School (P.M.S.) 6300 Zug, Switzerland;
- University of Leeds (GB)
- Massachusetts General Hospital (US)
- Clinical Trial and Consulting (US)
- Sahlgrenska University Hospital (SE)
- Corresponding author
- Stewart, Paul M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-09-13
- Volume
- 101
- Issue
- 12
- Pages
- 4843-4850
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2519685034
- Semantic Scholar
- ebe36a63a3ded2c61dcc026a993c79477c76d04d
- Cited by
- 90
- References
- 44
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 9 · 2023: 9 · 2022: 6 · 2021: 17 · 2020: 9 · 2019: 5 · 2018: 10 · 2017: 6 · 2016: 1
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0514-10090, NF-SI-0508-10356)
- Novo Nordisk Fonden (NNF15OC0015922)
- Medical Research Council (MC_G0802521, MR/K015176/1, MR/K015176/2, MR/K015184/1, MC_PC_15055, MC_PC_15046, MR/K00414X/1, MC_PC_13066, MC_G0802531, MC_PC_14109)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- adrenal insufficiency, Addison's disease, pituitary disorders, congenital adrenal hyperplasia, hospitalization, morbidity, comorbidities, diabetes mellitus, depression, anxiety, hyperlipidemia, hypertension, infection, steroid replacement therapy
- MeSH terms
- Adolescent, Adrenal Insufficiency, Adrenal Hyperplasia, Congenital, Adult, Aged, Anxiety, Depression, Diabetes Mellitus, Female, Hospitalization, Humans, Hyperlipidemias, Hypertension, Inpatients, Male, Middle Aged, Pituitary Diseases, Retrospective Studies, United States, Comorbidity, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.